Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities

High-dose methotrexate is a cornerstone agent in the chemotherapeutic treatment of patients with osteosarcoma. However, patients often develop methotrexate-induced toxicities. We aim to identify determinants of methotrexate-induced toxicities in osteosarcoma patients by investigating the relation be...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurkmans, Evelien G. E., Klumpers, Marije J., Vermeulen, Sita H., Hagleitner, Melanie M., Flucke, Uta, Schreuder, H. W. Bart, Gelderblom, Hans, Bras, Johannes, Guchelaar, Henk-Jan, Coenen, Marieke J. H., te Loo, D. Maroeska W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435008/
https://www.ncbi.nlm.nih.gov/pubmed/32903464
http://dx.doi.org/10.3389/fphar.2020.01241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435008/
https://www.ncbi.nlm.nih.gov/pubmed/32903464
http://dx.doi.org/10.3389/fphar.2020.01241

Ejemplares similares